Skip to content
Dosage GuideResearch Reference

Lactoferricin Dosage

Research-based dosing protocols, timing guidance, and reconstitution reference for Lactoferricin. All information is for educational purposes only.

Quick Answer

Due to limited human trials, lactoferricin dosage is primarily based on in vitro and animal studies. Oral dosages in animal models range from 5–50 mg/kg. Human equivalent dosages, if extrapolated, would suggest a wide range. However, bioavailability, degradation, and optimal routes of administration are still under investigation, making definitive dosing recommendations premature.

→ Lactoferricin Benefits→ Lactoferricin Side Effects→ Full Lactoferricin Profile
Table of Contents

Standard Dosage Range

Research dosing range: No established human dosage. Animal studies range from 5-50 mg/kg.

Educational reference only

These dosage ranges are derived from preclinical research and community protocols. No human clinical dose-ranging trials have established therapeutic doses for most research peptides. Always consult a qualified healthcare provider before starting any peptide protocol.

Dosage by Use Case

Antimicrobial Support (In Vitro / Animal Research)

0.5-5 mg/mL (in vitro); 5-50 mg/kg (animal studies)N/A (in vitro); 1-2x daily (animal studies)
Duration

Variable; study-dependent

In vitro concentrations are often cited as a reference point. Animal studies vary widely based on the target pathogen and route of administration. No human data to extrapolate from.

Anticancer Research (In Vitro / Animal Research)

1-10 mg/mL (in vitro); 10-50 mg/kg (animal studies)N/A (in vitro); 1x daily (animal studies)
Duration

Variable; study-dependent

Effective anticancer concentrations in vitro are generally higher than antimicrobial concentrations. Animal studies used varying durations and routes of administration (oral, intraperitoneal).

Immune Modulation (In Vitro / Animal Research)

0.1-1 mg/mL (in vitro); 5-20 mg/kg (animal studies)N/A (in vitro); 1x daily (animal studies)
Duration

Variable; study-dependent

Lower concentrations and dosages may be sufficient for immune modulation effects. Animal studies investigated effects on cytokine production, NK cell activity, and macrophage function.

Timing & Frequency

Timing is not well-established due to limited human data. In animal studies, lactoferricin is often administered orally or intraperitoneally once or twice daily. The half-life and optimal dosing frequency in humans are unknown.

Cycle Guidance

Due to the lack of human safety data, long-term cycling recommendations are not available. Any potential use should be guided by a healthcare professional and approached with caution. Given potential immunomodulatory effects, prolonged, high-dose use should be avoided without careful monitoring.

Reconstitution Reference

Quick reference for reconstituting Lactoferricin. For custom vial sizes and concentrations, use the Reconstitution Calculator.

Common Vial SizeTypically supplied as a lyophilized powder in varying vial sizes (e.g., 10 mg, 50 mg).
BAC Water VolumeVolume depends on desired concentration. For example, 1 mL of sterile water per 10 mg of lactoferricin yields a 10 mg/mL solution.
Concentration & DrawVariable; depends on the desired concentration. See water volume calculation.
StorageLyophilized powder should be stored at -20°C for long-term stability. Reconstituted solution should be stored at 2-8°C and used within a short period (e.g., 1-2 weeks) to minimize degradation.
StabilityLyophilized powder is stable for several years when stored at -20°C. Reconstituted solution is less stable and should be used promptly.
Use the Reconstitution Calculator → for precise injection volumes based on your exact vial size, water volume, and desired dose.

Frequently Asked Questions

What is the recommended dosage of lactoferricin for humans?
There is no established recommended dosage for humans due to limited clinical trials. Dosage recommendations are premature until more human data is available.
How should lactoferricin be administered?
Route of administration is not well-defined for human use. Animal studies have used oral and intraperitoneal routes. Oral bioavailability and potential for degradation are important considerations. In vitro research often tests direct application of solutions.
What are the potential side effects of lactoferricin?
Side effects are not well-characterized in humans. Animal studies have reported some gastrointestinal disturbances at high doses. Allergic reactions are possible, as lactoferricin is derived from milk. Consult a healthcare professional before use.

Last updated: 2026-02-19